ArrowMark Colorado Holdings LLC Buys Shares of 2,900 UnitedHealth Group Incorporated (NYSE:UNH)

ArrowMark Colorado Holdings LLC bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 2,900 shares of the healthcare conglomerate's stock, valued at approximately $1,467,000.

Several other large investors also recently made changes to their positions in UNH. Principal Financial Group Inc. grew its holdings in shares of UnitedHealth Group by 11.3% during the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock worth $1,039,933,000 after buying an additional 180,479 shares in the last quarter. Pensionfund Sabic raised its holdings in shares of UnitedHealth Group by 48.4% in the fourth quarter. Pensionfund Sabic now owns 9,350 shares of the healthcare conglomerate's stock valued at $4,730,000 after purchasing an additional 3,050 shares during the last quarter. Kings Path Partners LLC boosted its holdings in UnitedHealth Group by 11.4% during the fourth quarter. Kings Path Partners LLC now owns 3,300 shares of the healthcare conglomerate's stock worth $1,669,000 after purchasing an additional 338 shares during the last quarter. Fortem Financial Group LLC increased its stake in UnitedHealth Group by 16.7% in the 4th quarter. Fortem Financial Group LLC now owns 818 shares of the healthcare conglomerate's stock valued at $414,000 after buying an additional 117 shares during the last quarter. Finally, Ables Iannone Moore & Associates Inc. boosted its stake in shares of UnitedHealth Group by 1.0% during the 4th quarter. Ables Iannone Moore & Associates Inc. now owns 3,848 shares of the healthcare conglomerate's stock worth $1,947,000 after buying an additional 37 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Down 0.5 %

Shares of UNH opened at $398.72 on Friday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $362.92 billion, a PE ratio of 25.72, a P/E/G ratio of 1.37 and a beta of 0.61. The firm's 50 day moving average is $495.85 and its 200-day moving average is $528.45. UnitedHealth Group Incorporated has a 12 month low of $393.11 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same period last year, the company posted $6.91 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 2.11%. UnitedHealth Group's dividend payout ratio is currently 35.18%.

Wall Street Analyst Weigh In

Several brokerages recently commented on UNH. Erste Group Bank cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday. Robert W. Baird lowered their target price on shares of UnitedHealth Group from $640.00 to $510.00 and set an "outperform" rating on the stock in a report on Tuesday, April 29th. StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Hsbc Global Res downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 22nd. Finally, Oppenheimer dropped their price objective on UnitedHealth Group from $640.00 to $600.00 and set an "outperform" rating on the stock in a research note on Monday, April 21st. Four analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $596.86.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.